Bai Ying, Mu Qianqian, Bao Xueli, Zuo Jiacheng, Fang Xin, Hua Jing, Zhang Dongwei, Jiang Guangjian, Li Ping, Gao Sihua, Zhao Dandan
1College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
2Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Aging Dis. 2021 Oct 1;12(7):1587-1604. doi: 10.14336/AD.2021.0318. eCollection 2021 Oct.
Diabetes, a common metabolic disease with various complications, is becoming a serious global health pandemic. So far there are many approaches in the management of diabetes; however, it still remains irreversible due to its complicated pathogenesis. Recent studies have revealed that nucleotide-binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome plays a vital role in the progression of diabetes and many of its complications, making it a promising therapeutic target in pharmaceutical design. Natural derived herbal medicine, known for its utilization of natural products such as herbs or its bioactive ingredients, is shown to be able to ameliorate hyperglycemia-associated symptoms and to postpone the progression of diabetic complications due to its anti-inflammatory and anti-oxidative properties. In this review, we summarized the role of NLRP3 inflammasome in diabetes and several diabetic complications, as well as 31 active compounds that exert therapeutic effect on diabetic complications via inhibiting NLRP3 inflammasome. Improving our understanding of these promising candidates from natural compounds in herbal medicine targeting NLRP3 inflammasome inspires us the relationship between inflammation and metabolic disorders, and also sheds light on searching potential agents or therapies in the treatment of diabetes and diabetic complications.
糖尿病是一种伴有多种并发症的常见代谢性疾病,正成为全球严重的健康大流行疾病。到目前为止,糖尿病的管理有多种方法;然而,由于其发病机制复杂,糖尿病仍然不可逆转。最近的研究表明,含吡咯结构域的NOD样受体蛋白3(NLRP3)炎性小体在糖尿病及其许多并发症的进展中起着至关重要的作用,使其成为药物设计中一个有前景的治疗靶点。天然衍生的草药以其对草药等天然产物或其生物活性成分的利用而闻名,因其具有抗炎和抗氧化特性,已被证明能够改善高血糖相关症状,并延缓糖尿病并发症的进展。在这篇综述中,我们总结了NLRP3炎性小体在糖尿病和几种糖尿病并发症中的作用,以及31种通过抑制NLRP3炎性小体对糖尿病并发症发挥治疗作用的活性化合物。增进我们对这些来自草药中靶向NLRP3炎性小体的天然化合物的有前景候选物的理解,激发了我们对炎症与代谢紊乱之间关系的认识,也为寻找治疗糖尿病和糖尿病并发症的潜在药物或疗法提供了线索。